HIGHLIGHTS March 2025 Tolmer discovery hole ranked 5th highest-grade silver intersection reported globally during H1 2025, with an interval of 6m @ 4,747 g/t Ag from only 46m depth1 New assays have ...

Award-winning GPU-based RAID solution delivers unmatched resilience and efficiency for modern HPC and AI workloads. SANTA CLARA, CALIFORNIA / ACCESS Newswire / August 7, 2025 / Graid Technology, ...

Indiana company says new drone regulations will speed improvements to package delivery security for Americans INDIANAPOLIS, IN / ACCESS Newswire / August 6, 2025 / Arrive AI (NASDAQ:ARAI), an ...

Gryphon Stockholder Voting Has Commenced for Special Meeting to Be Held on August 27, 2025 Gryphon’s Board of Directors ...

NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...

Global Fintech Doubles Down on ESG Commitments to Build a More Sustainable and Inclusive Future BOULDER, CO / ACCESS Newswire ...

MISSISSAUGA, ONTARIO / ACCESS Newswire / August 6, 2025 / Consumer Choice Award is pleased to announce the 2025 award recipients in the Peel Region. These businesses have been meticulously selected ...

LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), an ...

WHITBY, ON / ACCESS Newswire / August 6, 2025 / Consumer Choice Award is pleased to announce the 2025 award recipients in the ...

Key Points GAAP loss per share of $0.55 in Q2 2025 beat analyst estimates by $1.13. GAAP revenue of $5.5 million in Q2 2025 missed expectations by 26%. Advanced key clinical programs, with first U.S.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor Filing based on unprecedented data package that met all primary endpoints across ...